Stateoftheartonanti-HIVchemotherapy <C>:!FI/950-6

(1)

FI/950-6

^,0,*()+_MSM%Men who have sex with men&^MSM^3128#.Networks in Asia

'G@" "" = #& G%K& "$ " $! $ "% " $! ';A"B";A %HE4#7%J&&

?D QGKEC

DMJ- #URX/a5T\H'(%&S9$

#`;1DbP4P4.6=4:82$

SSY !! Gay Sauna Networks : Understand- ing sex on premises venues for pre- vention and support interventions

Jeffrey Grierson

Senior Research Fellow, Charles La Trobe Fellow in Male to Male Sexual Practice in the Asia / Pacific Region/

Australian Research Centre in Sex, Health and So- ciety, La Trobe University, Melbourne Australia

SSY !" Feasibility of Implementing and As- sessing an HIV Risk Reduction Edu- cation Network Intervention with Men Who Have Sex with Men in Nanjing, China

Kyung-Hee Choi^!, Juan Jiang^", Ningxiao Cao^"

!Center for AIDS Prevention Studies, University of California, San Francisco, USA

"The Institute of Dermatology, Chinese Academy of

Medical Sciences, Nanjing, China

SSY !# The connectivity of MSM in Hong Kong: findings from the SNA survey among HIV positive MSM

Shui Shan LEE

Stanley Ho Centre for Emerging Infectious Dis- eases, The Chinese University of Hong Kong, Shatin, Hong Kong

'G@" "" = #& G%K& '" $! $ "! " $! ';A"B";A %HE4#7%J&&

<C>:" ?D V3 d #AbY.7?`;1,c)+*"$

KL ! Seek and Treat for Optimal Prevention of HIV/AIDS " STOP HIV/AIDS #

Julio Montaner

BC-Centre for Excellence in HIV/AIDS, Providence Health Care Division of AIDS, University of British Columbia

International AIDS Society

'G@" "" = #& G%K& "! " $! $ "" " $! ';A"B";A %HE4#7%J&&

<C>:# ?D 0_ F#`;1DbP4,4:82IO^<!N@ ,4L>IO7W[C,4B][CIZ4$

KL " State of the art on anti-HIV chemotherapy

Erik De Clercq

Rega Institute for Medical Research, K. U. Leuven

<C>:!FI/950-6

(2)

'?7" "" 2 #' ?%1& "% " !! $ "% " $! '/:";"/: %@=+#-%B&&

(-*,#)9

-302!.FHB8

QINGD

WRX7^=VZL*,#&T@

'?7" "" 2 #& ?%C& "& " !! $ "' " !! '/:";$/: %46/08&

>A3." 5< 6=DC "B;A/A/+*?!>,1.-#

SL ! HIV ]M>E)?6K"YC($%+AJ'[PS

9U\_

YC/451-O<;:

'?7" "" 2 #' ?%1& "" " !! $ "# " !! '/:";"/: %@=+#-%B&&

>A3.# 5< 0@89"4E2<A/A/+5:'& $()%73-#

SL " Epidemiology, Scientific Networking and Prevention Tasks

in the Field of HIV/AIDS: the German Experience and the Competence Network for HIV/AIDS

Klaus Jansen

Competence Network for HIV/AIDS Clinic for Dermatology and Allergology Ruhr-University Bochum

(-*,#)9!>A3.

(3)

0<71,8"

.+2VM*@D=J)'(*

WOX?PEI\

0<71,8#

39"/;"4:,-"5)TZ

&TK! "" C #& T$[% "$ ! $! # "% ! $! &>N!Q$>N $FH>AL%

GR (S A#T4)?VH+%+2.*CGR5!F9

%+E6CG,MP>%+:QP>CO+$

8D7=#/KH+H+&%+2.1'!@XL+$

SY!$! @~nj(%&+ EB .-92Iª 8:6k

Y

VBGG>;GQSKC.-92G

SY!$" HHV-%H}'071k!primary ef- fusion lymphoma )t¤

¡y§

]¥H}tSKoH}¤

SY!$# HCV ' HIV ')_\H})©r

OJ

]¥]b;¨4:5#Wc>/-3i¨"SKF4:

5#

SY!$$ flH}t(*+ HIV |)«v' /-3t

^<R=

VBe¥GG>;GSKCad{G

&TK! "" C #' T$B% (! !! # "" ! !! &>N!Q">N $US6":$Y%%

GR U3BN

-IJW #/KH+H+&%+2.*$

#/K<0H+"MASH H;$

SY"$! A',1,) HIV ¦Z)Uu'

Tz

LGG>;GSKC

SY"$" A',1,') STD ¦Z)Uu '

q¡gs=

LhPE;CGH}wX

SY"$# )xZ)Uu']b

TDd

LGG>;GSKC

SY"$$ ) HIV ¦ZuN'p£¢

Mm

R?{G;G?{G[`

0<71,8

(4)

285316$

^)0'/,A_(P@ ^HIV^S>;,H.-

285316%

^HIVCQGN+*,R?:E

&MD! "" = #' M$<% (! !! # "" ! !! &9F!I#9F $OK4"7$L%%

BJ H. `

TGEU #=\V-5;Y9/,](+)!"=\3JF86C$

#A?QN2N2-,>2K<860W LS@&%*'VMI:86(+)!$

SY $$" HIV l¨1(+5 CCR &2rÀ

µ½´

Experimental Retrovirology Section, Medicine Bran- ch, NCI, NIH

SY $$# HIV Ì¦2Ú³i/%5º6É¸0 -5 ,&ÜÏ

¶})(4

Ó{`Û²j²jZYjxpdÐÎ¥Íj

SY $$$ ;#P=Bg§Ï*£±:8C

Ü"ÖÑÏhÇ1×'58WL=G

tÕ

Ûl¨xp:8CxpDWE#

SY $$% RNA Îgª MazF 6Çz-5 nU GV98TBO=E#6Ø&.:8CX

¼ÜÏ2hÇ

_Òc^"!·Õ[¢^#!ÆÈ^"

"¾²j²jZYj«xpdË®Â98TBÊ

°¤|xpDWE#

#E<SK8;kfK8;xp

&MD! "" = #' M$<% "% ! %! # "& ! %! &9F!I#9F $OK4"7$L%%

BJ XZP_

4O[1 #R7N2,0286C$

#=\V-5;Y9/,](+)!

^D86(+)!3JF86B$

SY %$" :WOV#N2¡b0µÞ~¯

a

uÒ²j:8CjxpDWE#Ê°¤|ÎÕ

SY %$# wdj135 HIV- " Gp "#! 2¬g§

^

Ûl¨xpÊy¯>JQg§xpDWE#

SY %$$ :WH?8G#@B6e,. HIV- "2 ÐÄ

oÁ¹

Ûl¨xp:8CxpDWE#

SY %$% HIV- ":WOV#NEWL= gp %" ?

MRIFG2mÅ

½©\

¿s²jYdjxp7A7l¨xpq»

µdjZ¥ÍÍÙxpÃµÝv¬98TBj"Ô]

jxp

285316

(5)

0421/3&

HIV-"9H*5GET

0421/3'

^HIV.OM,PG,+)(-'"

#L:SRBI-QGDA6-7K#

&NB! "" = #( N$<% "% ! %! # "' ! %! &8F!J$8F $>@8;C%

?L :> M

>YRK #WHU?a<ATOGD;091"$

#EcU?+*/?FB091"$

SY%$! HIV 8W¦æ8¼

Xb

·±iÊ]l®¥s\HVI#

SY%$" A@GmãW¦RVM

b¹ª

xÔ±iA@Gi|pHVI#

SY%$# HIV l®7Î03ÆzÊ

Ä~å¯ä

ÝYàHVI#z_¾c

SY%$$ BOE¿8âÊÜ5 HHV-'l®

Ð×¨ß

Ýl®|pl®ÊÜË

SY%$% È AIDS mãW¦æ8½¶$àÞ 528§«$

^¹X

,?"l®HVI#º¾wÊ]l®c

&NB! "" = #( N$<% "% ! %! # "' ! %! &8F!J%8F $8;C %$" + %$# %

?L WVS_I

QZ J #^c HIV dPL4238",!-69557.#JaNP%$$

#]X`=e@\bN()&'[C$

SY&$! HIV/AIDS à+<;3!Ê8DVK T#S

j^ÅÂ

ÝYàHVI#Ê]A@Gà"|pgÇHV I#

SY&$" »qº7*.=A@G£àráÊ]8

5d²

±Z Ø

»qºÍÑ{ul®°d

SY&$# »fµv7Ò<1 HIV Ú¦8à5

©k

¢×¡Ö LIFE»f

SY&$$ ·n7 HIV/AIDS àÛ>1=/5

%ÌÙ8y}+<

·³¬Å

ÀÔHIVÚ¦LJKU#C"EPVNNQF&JaNP ('

SY&$% µ[48àÛ©k>6)a1=+

bÔ i

ÝÊ]o±YàHVI#

SY&$& Õ`oÃh8Á¸58d²

±ÏÉ

eÍÓ¤9:3-Ít´

0421/3

(6)

2>;30<&

^/(D+').^HIV^BEKU

2>;30<'

8"67"259CM,*-,TJ 41=

&QG! "" A #' Q$P% (! !! # "" ! !! &?I!L"?I $RO:"=$S%%

FN I!;8

/KE: #.>@Q6D$

#5V2CG1+1OMFP1!R-14B$

SY%#! 1&b-%'0 HIV \e.^t,L

Ju_

Z£TqNENxN!INXn

SY%#" E¡SQ-%'0 HIV \e~.W -*$+

Hj

gw43:g

SY%## ¢rE. HIV }Rv2(0`!

Fj-*$+

z ¤ 76BySOmMp

SY%#$ @">?"[v.of

d]i

YcGP|sK

&QG! "" A #' Q$P% "! ! $! # "# ! !! &?I!L%?I $?@H %$" + %$# %

FN HJU?#<S<=+T()"9>N, &%'AT!730L()"$

SY&#! @">?"8=A`.)/.{95C

Uu

VEKlKNNG

SY&#" ¡~,@">?"8=A

j

hk aE¡;D<"

2>;30<

(7)

3>;42<(

^HIVBQSI/)*18#67#

359'MLR.NGO0DY

3>;42< "!

^HIV\JBQ_]SI0P?!

,+-@U

(ZK" "" E #' Z%X& "% " $! $ "& " $! (AO"T"AO %[W:#=%^&&

GV @TZ<

[QU^ #&%'(-,+(" RainbowRing $

#1VC:>XD9:>/OWY:E83E8JI3$

SY(%" äqâ6+,> MSM 97DBIÐ7 -?:4%äqâ+<8ì_ ú|² 47¬=Ë;%

á\

ì_ ú|²ú|ÐdiÉ¸ÐÖå

SY(%# EBFOPMLA@ý*>º¯xú|² 7¬=Ë;

)æ

º¯xø£÷0«G$NHd&º¯xú|²

SY(%$ #` 7 MSM 97DBIÐ7¬Ë

;%Àc5dÓ

ÕX¶ë

#` |ø£u|÷|Í½d

SY(%% NGO 5×þÁ72z

"Á

,ôWmwS.JRK$$[iÉ¸b&iÉ¸Ð

¨

(ZK" "" E #' Z%X& "% " $! $ "& " $! (AO"T$AO %FHACN&

GV S=K5

4NLM #BG;\P?0]).*!$

#RAC\P?0]).!HF0]).!HF762$

SY "! %" HIV üiÉ*!Ð7Àc

kÎ4^"^"^#!o'Û¾^#!fÈÃÄ^#!Ü(^#! Òãs^#!V+}ë^#!4á)T^#

"ÝqÒgSg÷ö¾bg

#Ä3çbgpðû´vDBIÐp¤t'HIVi Éêö507°Ä¥7Ú#eÆ+<8¼.#¡]Ï¿7 Âñ6j/>ÌÞp(ï

SY "! %# êö HIV ~ %é%þ§62)3

Òãs!V+}ë 5rSbÒgbö¾bgs¨

SY "! %$ Ò×x47{

î Ç®

,ôWmÒS.JRK$ö¾b

SY "! %% åW6+,> HIV üiÉ*!Ð@

UÔ.1¸/7&Óà57dÓ

ÙÅóª³

,S.JRK$ôWö¾b

SY "! %& HIV üiÉ*!ÐõhÊ©¢/6+

,>ºÄ¥7CBQH.ÿ

È»T!Ù±!YÄZ!æß!

·aØ¦

,S.JRK$µ¥b

SY "! %'

èùí Ð^6y -.1ê¹liÉn)7T/

1òÑë

,ôWmwS.JRK$ö¾b

3>;42<

(8)

9A>:7? ""

^HIVEH1PWO0-(.I)5#

#,1BV6T2J3+//EH64*5=;<@"81DX

'UL! "" G #' U%S& "% ! $! $ "& ! $! 'CN!Q%CN %CFM %$" + %$# &

KR $.:,

9453 !8/0'"

!2(17)#;+-&*6%"

SY !! $! G{6`<1Ki5;w*+2

xmG

zPyUFZhIXH

SY !! $" jnvu23.,f(8 HIV MY5 po4/&0^':

sWc

|iU[eO\SaH

SY !! $# G{6`<-MY;^':

%gr;l9.0%

~

)<!Lqk@EA#yR`H

=CEB#A#"

dQTc

MY?B#>DE}b _]79c

NVMYtJtJH

9A>:7?

(9)

`Q!NA3=:

4 ? ; 5 1 <

^MSMNA+-0?7#8206

$$`Q!IK!NA-F[

DU!`Q3=:

4 ? ; 5 1 <

^DUJE$`QJEB-S*,TZ/W.

)]M" "" H #& ]'_( "( " !! & ") " $! )AR"V#AR '^Y9#>'\((

LX B+:AU

5?IE #>GOC&%'VQ>G"S7/@WF1281L$

#S7/@WF1F1-281640$

ý°!¥l$! ý°²+:; MSM

¯Í û

ÝÏ{UFJ~G]I#

ý°!¥l$" 6²+:1 MSM $ HIV 5s¾ /2)4)Èáã6 MSM 76s¾<æ -195$

½ÙÊî

Èàú«eºzs¾±á>=ZEk

ý°!¥l$# óæÚ!ø¸¦¡g6²+:;

MSM

½ª©

Ëäµ?=FóæË

CW]L#I#"

ty}µ W=M>TERIZ

)]M" "" H #' ]'G( "& " %! & "( " %! )AR"V#AR '^Y9#>'\((

LX 5Y H

.RJ; #S7/@WF1F1-,1640=PN?DM1NT$

#<WK-39S7/,X(*)!$

uÀ!ý°$! HIV- "s¾±3 TRIM %α

ÌdÜ

ÈÈpÛºâÞz>=ZEs¾·ãï

uÀ!ý°$" ÔçÓ5*.;PMëfß¿>=ZE

"& HIV- "'s¾±þ6´ü

hèÖ

úÞbvéi_üG]I#

uÀ!ý°$# HIV C[GSI#3/2Ð,(I]OA£

|ð¨ôÄ6Ãõ¸3Ò^¸

¹¶¼ê

×ÈpÈpb_pzjã óæ_p

uÀ!ý°$$ CCR %Áo5Å0;Æ¸v®%ý°

ãùr<ö)1UYQ\KAÆ¸òÑ%

wÂ!x

çÈp?=FpzG]I#ÞÇ·ãï

uÀ!ý°$% =]LB[#DX]6ã W@NFV3

å¸a $³/)Áo6nÚ58.

2

ÿìø`

{ÎÈp>=ZEz¬§÷am»J#V

uÀ!ý°$& =]LBY#HÁoñ& raltegravir '6ý

°²5*.;¤36íÉ

qcØÕ

ú_üG]I#Þb?=F¢ü!znÚG]

I#

OPC@%`Q!NA3=:4?;51<%DU!`Q3=:4?;51<

(10)

ADJ-).- 3"72?:/>?7

4 8 = 0 9

5?;61<"

^HIV^ETMOI,*(+

'SK! "" C #( S%R& )! !! $ "! ! #! '@N!P%@N %@BL %$" + %$# &

GQ :9 1#4=45+>()"36<, &%'7>!20.;()"$

NCC &! HIV É!×7G=B5Aþ/É3

)+!û

ñ±Ü^!!$ïN^!!ÏX^! £ ú O^"

!JAëZÒÁ~{´ÞPbyà ^"JAëZÒÁ~{´ÞP qQÓU

NCC &" Care .,+ Drug use /Õ HIV a º/!û

p©Ü¢!V¿Xo!®î!Ï

|Ã^M^àß¾ÞPbyà

8EI>%<%#

¹| ü

¬_Ã^M^½ÞPaºcöà RóT

÷ÞPhÃMù;I<%byà

©®j

÷ÞPhm Mù;I<%byà

'SK! "" C #& S%U& "' ! "! $ ") ! "! '@N!P$@N %FH@BL&

GQ /8 -#4=45+>()"36<, &%'7>!20.;()"$

SS !&! HIV ¯ù/vª-WÄ

ÙÅí

÷ÞPhÃMù;I<%HIV/AIDS¸ÆMù[Û

;I<%

SS !&" qQµ.01 HIV ' HCV ¢áaº`

.À*1dK«

r¥øÖ!| !Ìz!ÖÓ}¤!

Ôl§!¼îÝ ËÃ^Ã^PK«"¦Sg\U

SS !&# éK«æç.01K«xi/äS/

sÑ

ÃJ}ã^!!¡ÏÍØ^"!w¹õ^!!ÊÐ³õ^#!

ãñîf^"!ìóã^!

!ëZÒÃ^M^àn²\U!^"ËÃ^M^àn²\U!

#ËÃ^Ã^PMò^½tkUß¾uÚxL¨]M ùtk·å»¨]Y¶àðþ"¯ÈÞö^tkâñ

SS !&$ 2(/ HIV eýFD?49@HC4%

/Â-ùÎè

¡ÏÍØ

ËÃ^ÞPn²\U

#Çç°65:ôêÇ

ADJ-).-3"72?:/>?7#48=095?;61<

(11)

B I P > J

CSMD?N#

HIV&@>F4485k-<i#6^`!.:/!dU

%l[HIVwje"#!!i6kVcmo\6XT9;%

B I P > J

CSMD?N$

^HIVwje6OSGQLQE76=KR$H 'hxg,u_0vs4A=52+36Zq 16"'

ra" "" Y #' r(t) "( " !! ' #! " !! Uf"n&Uf (UWb "%" + "%# ) ]p B]/01

GM ? ">9:\H6#

"PLR4Y7OTF()%&N8#

SS"$!

M¤ R

o¯JZlsI°>H?#

SS"$"

Uhi

`²\RRJbjCA;DH@c]O

SS"$#

¦x HIV/AIDSWgRQ

|q"r¡75=¬¢r

ra" "" Y #' r(t) "( " !! ' #! " !! Uf"n'Uf (UWb "$" + "$# ) ]p V5W[@

;=JC "<ITF+*,XU<I#

"QKS3')$%-2.!^DEZA#

SS#$! HIV {/:4e-P"86H>

FH9/e02

£ª¥«x

SRIyRnJVX®

SS#$" DH?GBG<©/Yd!L-

O-/±a.+&,&

OI/¯(1

v¤k

o¯JZl^}I°>H?#§KVO%Vt z

SS#$# DH?GBG<©/Yd!L-

O-/±a.+&,' 86H>E#/¯(1

¥®x

o¯JZl^}I°>H?#Vt%r¡75

=¬¢r

SS#$$ DH?GBG<.')3¬¢-:4

(_x

~R

SS#$% OI(1d*®/T/N

-pf

u¨mw

[JO

BIP>JCSMD?N

(12)

9 ? I 6 @

:MF;7G$

ceQY`,a.VX"

SEX'WORK'HIV'LIFE

9 ? I 6 @

:MF;7G%

Z.Oh-_*-R024+)31.

$bW,\N,S-f/<AJ>H5K!85$

(e]" "" U #& e%g& "( " !! $ #! " !! (P^"BL=M<D#<%6CM@E#K&

[d 9 @2"71=A7+5-3*+>#

SS$$!

®z

x¡µ\_|Z\¢

SS$$"

y j

f\¤\ndYCR#LQCOE&¬m1pgm4 u¥=8+-?E?e'

SS$$#

± ¯cz SWASH

SS$$$

5>5>6;

SWASH

SS$$%

´kz

³W]¨CHARM

SS$$&

Xª0;z

`\V\\¢

~t"w¨A@G°©w

(e]" "" U #' e%T& "& " !! $ "( " !! (P^"BL=M<D#<%6CM@E#K&

[d ;18?"0A<(./71'B$&%!,64:)#

SS%$! HIV ²}1FMPJO?Q!D?%o

*:4¦r%

Xª0;z

`\V\\¢

SS%$" vT{*:4[§%BPFKh4µ

a

`\V\\¢

SS%$# 39</09:)2(i,7%£h

4µ*:%

¶\¨\¢

SS%$$ U·3l).(.2NSL#

x«

sµVbqxU·HSI#^Y

9?I6@:MF;7G

(13)

3 7 < 0 8

4>:51;&

^HIVXfQ?968="2%A-net&-Ve\

#ETOAJ-968="2/cP*+#

3 7 < 0 8

4>:51;'

^HIVF[]NLH,().YbU D-@dBaZ

'`R! "" K #' `%I& "( ! %! $ #! ! "! 'CW!^%CW %CGS %$" + %$# &

M_ 5I 0

.RN? $@T@B,U)+"=DP-'&(FU!;71O)+"%

$@TP-3>S</,U)+*"%

)ÂTã*

HIV¯÷XFCEL$<'A-net(/ù-eÃ rÉ a

ôQ÷AMB$áV:9@÷"wgÞAM B$

)ÂÙã*

¾·yÖWhÍ.+,5HAART/ïó ]êÜ

ôáVoì^Q÷AMB$

)Âã*

GFKD8?;C=IM

l `~/¯÷XFCEL$<.u246 53/-0

H9MGFJ$

cR£

NPOç°FCEL$<Q÷-°'MERS(

GFJ$

ZÕÇÛ^"!OÕ¤^#!Ðýaí^$!«Ðkâ^%!

Ñý Á^&!ÕRps^'!Ø öß⁽!t¬ÓÄ°⁾!

³Æ^*!Ì½±ß^"!!l ï

"éf×ÁháV!^#ôáVo¸ÀQ÷AMB$!^$i

ÁháV!^%¶¹ôÌ[áV!^&ôáVoÁQ÷A MB$!^'Ó Á h á V!⁽ ô á V o | ¢ Q ÷ A M B$!⁾}úûáV!^*õvÁhQhã!^"!ÔxÁhQbh

w¦

¡#Åç°:9@ðèÅ

'`R! "" K #' `%I& "( ! !! $ #! ! !! 'CW!^&CW %CGS "$" + "$# &

M_ 4JKV

AMH6 $8LE:G2#MASH GC%

$8LQ9G2%

SS(%" HIV mº¿w.+,5°å§h/P ë-îj

qÎÏü

xÒ{Áh&MASHÁ

SS(%# HIV mº¿w1/å_°øh/\ñ

µ ®Ú

xÒÁhÔØ7>7w¦

SS(%$ HIV mº¿w1/ÈSw/\ñ

Ð»æ

xÒ´dÁh°åhã

SS(%% HIV mº¿1/åhw/\ñ

ÕÐ¥

NÇhVÁhzòã

SS(%& HIV mº©-àªw

ÊÐ

¼UÐÁhYÝän&Ë/²¨ÁhÁhV

¡#Åç°:9@ðèÅ

37<084>:51;

(14)

2 9 A . :

3E?4/@(

6815D"0"*',+(#!!)

2 9 A . :

3E?4/@)

MYGKQ*RSJ)O[-165

&YN! "" I #' Y$H% "( ! !! # #! ! !! &FP!;C7E5="5$.<E:>"B%

LU B I5"=3DK=+<,9*+E#

SS'$!

¨{

x¯^`}[^

SS'$"

II!E!N!JEQ#F MASHx

SS'$#

« ©a{

SWASH

SS'$$

.3.3/1 SWASH

SS'$%

AKLOM6;

SEXY MOUNTAIN

SS'$&

y k

f^^ncZ:R#GPCOE&¥l+pgl, u¡20)*4=4d'

t"w¢75?ª£w

&YN! "" I #( Y$W% "$ ! %! # "& ! #! &FP!T#FP $ZV>"B$X%%

LU ?CH8

>A-7 "4J+)=+#

"0@;L:!('&$12F/.M6G%*#

SS($! \s,U±49@>,q+¤

-,Wj

k

4HO8¤hb[%w¢75?ª£wO<#BQ

=CSD

SS($" s_®,q+v° eX

o

]s_nc[!rz

SS($# si2(1 HIV ¬~+U±49@

>,m

4N6#=M OJ H#OM IN=PsY¦²®TV[|§TV

29A.:3E?4/@

(15)

K O S F P U#ILRNQ

HIVkYWn=.,9!@7:->1HGVMTVJEZm5C6?=#

$)HGVMTVJEb,6,2;A1D/B<,!

8<36,2;8<0B<,*&g^:`jE\l4A-$

+ic" "" _ #& i']( "' " #! % #! " #! +Xe"f%Xe 'X[d "$" + "$# ( ah 6( 2

.4*/ !9,#%3'+$5%"

!3-7:3'1)0&'8"

TÒíÓ

ïÕVn¼UðMSN&°«^

´

qÊ¼h¼hVUh~o^|W#£óÍ^h

¯¿è

qÊ¼hUhÛÚ»ÕV

Åq

¼Ùï¼h¬l¡bhÛ

[æ]

ïÕVn¼UðMSN&kÛ

Àä¤

ªi¼hUhºÕV

må¸Ö

2F#j·¦MSN&ÊïwÕVkÛ

«À¥

ËqÊÜÝ}u

%ãç

àU^¼hÚ»ÕVÍ^dì

±¶a

µê}ÜÛ

Zá h

ïÕVn¼UðMSN&

s\

ïUðMSN&ÕV(ÁÞ¬IGLéßÁ

-½!Û$JHSMRSKÌÏ;ñy>m5B©;`¾.

!"+ÅfpÉÕV>0/9DCBJHSMRSK?

E§46B~o,'Æ{_1A' Y¢$TÒíÓ

ïÕVn¼UðMSN&°«^

""ÅfpÉÕV¹Ãt?ÌÏ;ñy?©;`¾

'qÊ¼hUhÛ×»ÕV?¨'

Y¢$´

qÊ¼h¼hVUh~o^|W#£óÍ^h

¯¿è

qÊ¼hUhÛ×»ÕV

#"JHSMRSK?ÌÏ#ñy>m5Bîò#eÐ?

®î

Y¢$Åq

¼Ùï¼h¬l¡bhÛ

-½"Û$`¾cz?7@?Äx;Ø.

$"JHSMRSK?ÔëEÑÂ5B7@?Äx;Ø

Y¢$[æ]

ïÕVn¼UðMSN&kÛ

JHSMQ&?ï¨1A$Àä¤

ªi¼hUhºÕV

%"JHSMQ&;?Æ®)â³gÝ#ÎÇÆ®=<*

?Äx;Ø Y¢$må¸Ö

2F#j·¦MSN&ÊïwÕV

JHSMQ&?ï¨1A$«À¥

ËqÊÜÝ}u

&"JHSMQ&?XEO&P:ræ5B7@?Äx

;Ø

Y¢$%ãç

àU^¼hÚ»ÕVÍ^dì

JHSMQ&?ï¨1A$±¶a

µêÝ}Üu

'"JHSMRSK2Ôë8;DCB2!3á¬2²

vÈ:=/¨?Äx;Ø

Y¢$Zá h

ïÕVn¼UðMSN&

JHSMQ&?ï¨1A$s\

ïUðMSN&ÕV(ÁÞ¬IGLéß

Á

KOSFPU#ILRNQ

(16)

GM7A<86="

Beyond Japan!The evolving challenges of supporting life-long antiretroviral therapy KN7A<86=!VD/3+2J?:@65>9a]4O'2+1/

GM7A<86=#

&[P! "" I #' [$`% "& ! %! # "( ! %! &BS!W"BS $\Y;">$^%%

LX Annette Haeran Sohn

0F*2 "TREAT Asia#

"C4B.+.53=/A>;

<53')(!/A@8EH#

KS !$! Improvement and Challenges of Providing Antiretroviral Therapy in Asia

Praphan Phanuphak

Thai Red Cross AIDS Research Center

KS !$" The ethical impact of shifting global

health priorities and funding on the quality and sustainability of HIV care in Asia

GY

^YxRR

KS !$# Life-long antiretroviral therapy: Wh- at will happen if we cannot keep the promise?

Rico Gustav APN+

\k"[¥UsPu

&[P! "" I #( [$H% )! !! # "" ! %! &BS!W$BS $KNBFQ%

LX 0F*2

L96I "C4B.+.53=/A>;<53')(!/A@8EH#

";JD,1:G7-+K')(!%$&·/A>?KE#

KS "$! Raltegravir 0p§_c(3lt+4

HIV V{r«d0w¨

L i

j©HWh£eMF«<E=#

KS "$" H/')4 Raltegravir 0p§_c

¬z'21 !" &!%$# -0a

ª

KS "$# Etravirine %7E?EDE:&0p§_c

© N

Lq©q¢HV{O

KS "$$ Darunavir 5|.*,}X¥n0p§

_c

TI

=#

KS "$% HAART ~y¥0

S

fFOR`JO

KS "$& HIV INFECTION AS A CHRONIC IN-

FLAMMATORY DISEASE $ IMPLI- CATIONS FOR THE OPTIMAL USE OF HAART

Julio Montaner

BC-Centre for Excellence in HIV / AIDS, St Pauls Hospital, Providence Health Care

Division of AIDS, University of British Columbia International AIDS Society

\k"¡¦¥UsPu

6B>@9CAEUsPu

GM7A<86=

HAART/()2T+.ZC

#_URE-*,0HIV/AIDS

(17)

7:,0.-+/$

%E=! "" 8 #' E#D$ "% ! !! " "& ! %! %3?!A&3? #35> "%" + "%# $

@9;3 04.1#%&!,32')("57-/6*,32+$

/.2#$(13-#,#"

fxA~

mnPv7}5N6z;

zjl

Xus>4>r}5pYh

wQ b

Ds>4>r}5N6z;

=ykc

_^4;s>dBoe*3,#Boe;

{? q

T4;s>N6z;

Hgyti K\}5z;

H:FL

]Pv7}5SGCz;

]x ^

]Us>s>54>MOI;

8|W

Z}5EVR94*3,#

J["'2&+!)0)&2%3@`<a

7:,0.-+/

B46CF1)2*G<'(&

(18)

8 I 6 2 )/,*(-

&E9! "" 5 #% E$4% "$ ! !! # "% ! !! &1<!A"1< $GD+".$H%%

7C -/.#!1+%-20'0'$(,'*)&"

(vL cg)

l_Q$! .,{pI-p{LpnR0f{+21 /*

V ` yYuSei[S

l_Q$" 96xp/rK- HIV Ttbz

~dq

WsU^JuSU^S

(v} @#8<>:EH)

&Sa/.*/<8:D4G!C6AF?5' B3:F?#=#"

N|k

jwo76;jw%]OluSuSMU^S\XP

mh"jwo76;jw Zh"]Ol

8I62)/,*(-

;:'='@J=

;F?'HIV3>'0B

(19)

> A 7 = A

6 ; 8 " "

Compassionate and Effective HIV Care for Homeless, Substance Using and Mentally Ill Individuals

> A 7 = A 6 ; 8 " #

> A 7 = A

6 ; 8 " $

^HIV^L],OTD

> A 7 = A

6 ; 8 " %

^HIV30*OH1A9?2A4

&WK! "" I #' W$[% "# ! !! # "$ ! !! &BN!Q"BN $XS:"?$Z%%

JR N=HQ#;SP/4:G=.T*-+" HIV/

AIDS EI.T862O*-+"$

Barry D. Zevin

Physician Specialist, Tom Waddell Health Center, San Francisco Department of Public Health

HT"05).6!2&4#*AY=Z

&WK! "" I #' W$[% "# ! !! # "$ ! !! &BN!Q%BN $BFM %$" + %$# %

JR 5J 0#;S;<.T-+"9>P/ &%)?T!862O-+"$

LS"$! !j!>gr

`fIX

Qsm:DOdV8t+7,#Ba\i<

LS"$" !j">gr

WMck

hG8<d@u[KR8@PSu[

HT"%1-.(3/7AY=Z

&WK! "" I #' W$[% "# ! !! # "$ ! !! &BN!Q&BN $BFM "%" + "%# % JR RF L#M7KBP/$

; ]9

QsQU8t+7,#NWm:'&*Xt!LE?l+7 ,#

HT"oq_pAY=Z

&WK! "" I #( W$G% "" ! &! # "# ! &! &BN!Q#BN $XS:"?$V%%

JR DR U#(',C43@1A$

CfJbv

^Nd@Ba\i<

HT"eFpnAY=Z

>A7=A6;8"

"W#C*"W"CU\@5<A/

P('YE).+-

(20)

D F > C F

= B @ $ &

D F > C F

= B @ $ '

^Mb-86UAPOBEC$G%16Hn7#%^HIV^mSGX

D F > C F

= B @ $ (

^Pf^aiT\52*3^HIV-RNA^pch5,.9

D F > C F

= B @ $ )

)lZ" "" Q #( l'O( "" " &! & "# " &! )L]"d%L] 'LN[ %$" + %$# (

Wg P-VR#5OG/G/)(/U/72N6+ L.![9ML.!0ES,CXN$

LS#$! JRB3#>b/+'M7E<L-

§s

¯\µ±

n®ddXUd³dqj¬ oY¥]!¼r¨¥]!

f²Z¸¬

[ W

~·~U¸=S?#u¨X65<¸!qj`§=S

?#

l"NS=S I2#Ke_

)lZ" "" Q #( l'O( "" " &! & "# " &! )L]"d&L] 'LN[ "%" + "%# (

Wg D * Z#<WM)1;Q:-(X%'&" Y@72%'&"0E!S,72N$

h´^

~·¨Xi{°t\U¸=S?#

¹qj=S?#f!²Zqj¬

l" a³e_

)lZ" "" Q #( l'O( "" " &! & "# " &! )L]"d'L] 'LN[ "$" + "$# ( Wg TF I#K3HBM)$

«y

£kU]d¹pUd|

l"R:O!@539F;B4A8;e_

)lZ" "" Q #) l'j( "# " !! & "$ " %! )L]"d&L] 'LN[ "%" + "%# (

Wg >F8?#K3JW4=M)0EA.$

G#C! ]

c» %£k]d¤m¨X&

¢,(% ¢]8PEA8&

®x¦%£kU]]dd¬ª¨X}¸]

8P#SQ#L]a¶&

G#C" ¥]

gv%.)+¥]¸&

z%£w8PEA8&

Vu¢Wº%+1(0¸&

l"NS=S I2#Ke_

DF>CF=B@$

`I09HAART

/:-86HIV_o5,.9<EA?<6 Ke;V+9&kJ!YJ6R^4Ke&

(21)

0 7 6 ; 1 3 9 5 " "

0 7 6 ; 1

3 9 5 " #

Improving the Management of HIV Diseases HV+/>.HIV?KHJU-24

PE! "" A #% P$T% "' ! !! # #! ! !! =I!M"=I $QO8":$S%%

LBD= UE J

R/WS "K4IAO,#

"5QG1G1,*1V183P6-L0![:OL0!2DT.BXP#

ES!$! HIV ^(»4Q.) !# «

³

¡c¬R

ES!$" »Z~4_T4¸

©y²

sº¬R`oyO»@NB#HIV/AIDSO»hb Zª@NB#

ES!$# 0+µx4|·fj

´z¨a

sºswO»@NB#l{¬R98?»!hbZª@N B#

ES!$$ ]4-6i1n HIV »°

¨}

¦±HIV¹GCFM#:!=KNHHL>&JaNP*'

dv";L:A!>I>:L8N\X

PE! "" A #& P$@% "' ! !! # #! ! !! =I!M"=I $QO8":$S%%

CN H+P >9FN

HMP CU Z "K40G1O,Y?7<1;=#

"2D@$)%(&)'#

P® £¯pS

ES"$! US 24 HIV ^»3,/7W

Ann M Khalsa

Centro de Salud Familiar La Fe C. A. R. E Center, Texas, US

¥® Interactive Session

ES"$! ½-6[5 HIV ^»4<D

%HIV ^»3,/7W

Ann M Khalsa

<JNE#B#

¶ q

¡Y[O[®¬Rr¤V {k§

¡cOV[¬R¼gtO[pu U¢ ¾

¡ceXOV[^m®

dv";L:A!>I>:L8N\X

076;1395"

HIV?KH(FU-G<,)

&M"$R'

(22)

^ F b L OQK]b"

^ F b L OQK]b#

^ F b L OQK]b$

^ F b L OQK]b%

^ F b L OQK]b&

+w" "" j #' '( "# " !! & "$ " "! +e{"WaPbMY#M'EXbRZ#`(

p 2?H3R$')&(DQC%

@LPG#E#

Ann Khalsa

&_n'7 ]U"?M>D!AKA>M:P[iVj

+w" "" j #( 'h( *" #! & "! " &! +e{"WaPbMY#M'EXbRZ#`(

p -"0 .+"1$M>5BPF7F748@7<;6# AGKE,*/OLAG%

bf Jeffrey Grierson La Trobe University

&uhv'7

@LPG#E# x p 38(+y^

Rld

~rtY

+w" "" j #( 'h( "" " &! & "# " &! +e{"WaPbMY#M'EXbRZ#`(

p I=9J!:H3N$AGKE,*/OLAG%

&_n'7

+w" "" j #( 'h( "% " !! & "' " !! +e{"WaPbMY#M'EXbRZ#`(

a=O!a=I)61s751

J9.e'(-

2*4/1 AIDS$;:B%

HIV0o`!m}CPE#

LGBT

1,41

SST

AGPyW

kc"qX;:BH# in NAGOYA$WADN%

+w" "" j #) '( "! " !! & "" " %! +e{"WaPbMY#M'EXbRZ#`(

kc"{w|SZzo CRIATIVOS-HIV!STD \gTCPE#$>N9F#Q<A%

^FbLOQK]b

st)Male STDs: Action Guidet:3>:STDUbSVQI*

C23~:c<:DIOMmz:v=

H#MR^_D:HIV~y:o-?.41A@06

$:HIV~y:QOLmz9-1A@06;89-$

GENq;7,B@:-$|}d9m/5 'HIV%GEN:i6q:nl:f(

miniJ[#O\T#

V^L`:HIV/AIDSr#&:=

$L]O!D^F#L]:g-?k@uxe:$

(23)

G 6 J :

=?9FJ&

G 6 J :

=?9FJ'

+UP# "" N #( U(S) "# # !! ' "$ # !! +KQ#AI>J;C$;(5BJ@D$H)

D@!NPO JF.-&),/'

+UP# "" N #( U(S) "$ # $! ' "& # $! +KQ#AI>J;C$;(5BJ@D$H)

STD =EI? CA*&+/("

H;B>

B>:70439863

D@!G<2157# in NAGOYA$WADN%

G6J:=?9FJ

HIV&75</M0R-2

%"))%V!.1/-175<3O,

E$;";8H4?A*LTWXK

(24)

+ 1 '

&</" "" * #' <$;% "% " !! # "& " $! &'3"7%'3 $')0 "$" + "$# % ,8 *#')!&,+%-$/(."

(HG5AY)

pmO[

QfbIjD

(R HIV r5Kad\

%d34,/2+?;@>%)

Mq^P

UujDLSbXCv<@=$rWE

(`w-9I7R HIV vn)

JVsF

gNCEbIjDrWl

*oT_G6!hojDrWZG5ieT_G]TcB

&!##"cB'.kt0:81"

+ 1 '

?4#">:HIV(625@!=9

A-.+1'

Stateoftheartonanti-HIVchemotherapy <C>:!FI/950-6

FI/950-6

'G@" "" = #& G%K& "$ " $! $ "% " $! ';A"B";A %HE4#7%J&&

?D QGKEC

DMJ- #URX/a5T\H'(%&S9$

#`;1DbP4P4.6=4:82$

SSY !! Gay Sauna Networks : Understand- ing sex on premises venues for pre- vention and support interventions

SSY !" Feasibility of Implementing and As- sessing an HIV Risk Reduction Edu- cation Network Intervention with Men Who Have Sex with Men in Nanjing, China

SSY !# The connectivity of MSM in Hong Kong: findings from the SNA survey among HIV positive MSM

'G@" "" = #& G%K& '" $! $ "! " $! ';A"B";A %HE4#7%J&&

<C>:" ?D V3 d #AbY.7?`;1,c)+*"$

KL ! Seek and Treat for Optimal Prevention of HIV/AIDS " STOP HIV/AIDS #

Julio Montaner

'G@" "" = #& G%K& "! " $! $ "" " $! ';A"B";A %HE4#7%J&&

<C>:# ?D 0_ F#`;1DbP4,4:82IO^<!N@ ,4L>IO7W[C,4B][CIZ4$

KL " State of the art on anti-HIV chemotherapy

Erik De Clercq

<C>:!FI/950-6

'?7" "" 2 #' ?%1& "% " !! $ "% " $! '/:";"/: %@=+#-%B&&

(-*,#)9

-302!.FHB8

QINGD

'?7" "" 2 #& ?%C& "& " !! $ "' " !! '/:";$/: %46/08&

>A3." 5< 6=DC "B;A/A/+*?!>,1.-#

SL ! HIV ]M>E)?6K"YC($%+AJ'[PS

9U\_

'?7" "" 2 #' ?%1& "" " !! $ "# " !! '/:";"/: %@=+#-%B&&

>A3.# 5< 0@89"4E2<A/A/+5:'& $()%73-#

SL " Epidemiology, Scientific Networking and Prevention Tasks

in the Field of HIV/AIDS: the German Experience and the Competence Network for HIV/AIDS

Klaus Jansen

(-*,#)9!>A3.

0<71,8"

0<71,8#

&TK! "" C #& T$[% "$ ! $! # "% ! $! &>N!Q$>N $FH>AL%

GR (S A#T4)?VH+%+2.*CGR5!F9

%+E6CG,MP>%+:QP>CO+$

8D7=#/KH+H+&%+2.*1'!@XL*+$

SY!$! @~nj(%&+ EB .-92Iª 8:6k

SY!$" HHV-%H}'071k!primary ef- fusion lymphoma )t¤

SY!$# HCV ' HIV ')_\H})©r 

SY!$$ flH}t(*+ HIV |)«v' /-3t

&TK! "" C #' T$B% (! !! # "" ! !! &>N!Q">N $US6":$Y%%

GR U3BN

-IJW #/KH+H+&%+2.*$

#/K<0H+"MASH H;$

SY"$! A',1,) HIV ¦Z)Uu'

SY"$" A',1,') STD ¦Z)Uu '

SY"$# )xZ)Uu']b 

SY"$$ ) HIV ¦ZuN'p£¢

0<71,8

285316$

285316%

&MD! "" = #' M$<% (! !! # "" ! !! &9F!I#9F $OK4"7$L%%

BJ H. `

TGEU #=\V-5;Y9/,](+)!"=\3JF86C$

#A?QN2N2-,>2K<860W LS@&%*'VMI:86(+)!$

SY $$" HIV l¨1(+5 CCR &2rÀ

SY $$# HIV Ì¦2Ú­³i/%5º6É¸0 -5 ,&ÜÏ

SY $$$ ;#P=Bg§Ï*£±:8C

Ü"ÖÑÏhÇ1×'58WL=G

SY $$% RNA Îgª MazF 6Çz-5 nU GV98TBO=E#6Ø&.:8CX

¼ÜÏ2hÇ

&MD! "" = #' M$<% "% ! %! # "& ! %! &9F!I#9F $OK4"7$L%%

BJ XZP_

4O[1 #R7N2,0286C$

#=\V-5;Y9/,](+)!

^D86(+)!3JF86B$

SY %$" :WOV#N2¡b0µÞ~¯

SY %$# wdj135 HIV- " Gp "#! 2¬g§

SY %$$ :WH?8G#@B6e,. HIV- "2 ÐÄ

SY %$% HIV- ":WOV#NEWL= gp %" ?

MRIFG2mÅ

285316

0421/3&

0421/3'

&NB! "" = #( N$<% "% ! %! # "' ! %! &8F!J$8F $>@8;C%

?L :> M

>YRK #WHU?a<ATOGD;091"$

#EcU?+*/?FB091"$

8D7=#/KH+H+&%+2.1'!@XL+$

SY!$! @~nj(%&+ EB .-92Iª 8:6k

SY!$" HHV-%H}'071k!primary ef- fusion lymphoma )t¤

SY!$# HCV ' HIV ')_\H})©r

SY!$$ flH}t(*+ HIV |)«v' /-3t

SY"$! A',1,) HIV ¦Z)Uu'

SY"$" A',1,') STD ¦Z)Uu '

SY"$# )xZ)Uu']b

SY"$$ ) HIV ¦ZuN'p£¢

SY $$# HIV Ì¦2Ú³i/%5º6É¸0 -5 ,&ÜÏ

SY $$$ ;#P=Bg§Ï*£±:8C

SY $$% RNA Îgª MazF 6Çz-5 nU GV98TBO=E#6Ø&.:8CX

¼ÜÏ2hÇ

SY %$# wdj135 HIV- " Gp "#! 2¬g§

SY %$$ :WH?8G#@B6e,. HIV- "2 ÐÄ

SY %$% HIV- ":WOV#NEWL= gp %" ?

SY%$! HIV 8W¦æ8¼

SY%$" A@GmãW¦RVM

SY%$# HIV l®7Î03ÆzÊ

SY%$$ BOE¿8âÊÜ5 HHV-'l®

SY%$% È AIDS mãW¦æ8½¶$àÞ 528§«$

SY&$! HIV/AIDS à+<;3!Ê8DVK T#S

SY&$" »qº7*.=A@G£àráÊ]8

5d²

SY&$# »fµv7Ò<1 HIV Ú¦8à5

%ÌÙ8y}+<

SY&$% µ[48àÛ©k>6)a1=+

SY&$& Õ`oÃh8Á¸58d²

SY%#! 1&b-%'0 HIV \e.^t,L

SY%#" E¡SQ-%'0 HIV \e~.W -*$+

SY%## ¢rE. HIV }Rv2(0`!

FN HJU?#<S<=+T()"9>N, &%'AT!730L()"$

SY&#! @">?"8=A`.)/.{95C

SY&#" ¡~,@">?"8=A

SY(%" äqâ6+,> MSM 97DBIÐ7 -?:4%äqâ+<8ì_ ú|² 47¬=Ë;%

SY(%$ #` 7 MSM 97DBIÐ7¬Ë

SY(%% NGO 5×þÁ72z

#RAC\P?0]).!HF0]).!HF762$

SY "! %" HIV üiÉ*!Ð7Àc

SY "! %# êö HIV ~ %é%þ§62)3

SY "! %$ Ò×x47{

SY "! %% åW6+,> HIV üiÉ*!Ð@

UÔ.1¸/7&Óà57dÓ

SY "! %& HIV üiÉ*!ÐõhÊ©¢/6+

,>ºÄ¥7CBQH.ÿ

èùí Ð^6y -.1ê¹liÉn)7T/

SY !! $! G{6`<1Ki5;w*+2

SY !! $" jnvu23.,f(8 HIV MY5 po4/&0^':

SY !! $# G{6`<-MY;^':

%gr;l9.0%